Showing results (571-580 of 3,788) with videos related to

Sort By:
Pageof 379
Oncoimmunology|November 25, 2020
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contextureXin Liu, Yifan Cao, Kunpeng Lv, et al.
Oncoimmunology|October 26, 2020
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosisSandrine Nugteren, Jeroen A C M Goos, Pien M Delis-van Diemen, et al.
Oncoimmunology|December 26, 2022
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitroGloria Esteso, María José Felgueres, Álvaro F García-Jiménez, et al.
Oncoimmunology|January 23, 2023
In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancerTao Xu, Philipp Karschnia, Bruno Loureiro Cadilha, et al.
Oncoimmunology|January 6, 2023
Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesiclesJun Deng, Hui Ke
Oncoimmunology|July 2, 2021
Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AMLF Brauneck, F Haag, R Woost, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Oncoimmunology|June 9, 2021
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patientsDevayani Machiraju, Melanie Wiecken, Nina Lang, et al.
Oncoimmunology|June 9, 2021
A novel role for an old target: CD45 for breast cancer immunotherapyAnnat Raiter, Oran Zlotnik, Julia Lipovetsky, et al.
Oncoimmunology|June 9, 2021
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinomaTeng Wei, Matthias Leisegang, Ming Xia, et al.
Pageof 379